Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2007

Feb 26, 2007

29831_dirs_2007-02-26_7aae13f9-9f02-46f8-ba5a-e1d8c5afe8f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2007-02-22

Reporting Person: KINDLER JEFFREY B (Director, Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2007-02-22 Common Stock A 76680 Acquired 222779.00 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2007-02-22 Employee Stock Option (right to buy) $25.87 A 760000 Acquired 2017-02-21 Common Stock (760000.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2572.00 Indirect

Footnotes

F1: The reported transaction constitutes the grant of restricted stock units in settlement of the earn-out of previously granted Performance-Contingent Shares. These units will vest and become payable in shares of Pfizer Common Stock if and when the Company's three-year total shareholder return exceeds the median for the pharmaceutical peer group. Upon any such vesting, the issuance of the shares of Pfizer's Common Stock will be deferred pursuant to Mr. Kindler's deferral election. Upon Mr. Kindler's retirement or other termination of employment (other than for death or disability), any unvested restricted stock units will be forfeited.